|
Thermo Fisher
snp rb1 c 3121415 10 Snp Rb1 C 3121415 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rb1+c/SNP+RB1%2C+C___3121415_10/pm20508609-38-14-15 Average 86 stars, based on 1 article reviews
snp rb1 c 3121415 10 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
MyBiosource Biotechnology
rb1 c-terminal peptide ![]() Rb1 C Terminal Peptide, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rb1+c/rb1+c+terminal+peptide/pmc10827202-166-93-96 Average 90 stars, based on 1 article reviews
rb1 c-terminal peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Dawley Inc
ginsenoside rb1 restored cardiac function in isoproterenol iso induced heart failure model ![]() Ginsenoside Rb1 Restored Cardiac Function In Isoproterenol Iso Induced Heart Failure Model, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rb1+c/c+rb1/pmc12805542-96-1-14 Average 86 stars, based on 1 article reviews
ginsenoside rb1 restored cardiac function in isoproterenol iso induced heart failure model - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Store at -20°C for up to 24 months upon receiving the product.http://www.creative-diagnostics.com/RB1-antibody-241014-147.htm
|
Buy from Supplier |
|
Rabbit Anti-Human RB1 (C-term) Antibody, 400 µl
|
Buy from Supplier |
|
Rb RB1 C term rabbit polyclonal antibody
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Expanding the ligandable proteome by paralog hopping with covalent probes
doi: 10.1101/2024.01.18.576274
Figure Lengend Snippet: a , Structures of two inhibitors of the CCNE1:CDK2 complex – I-125A and I-198 – reported in a patent . b, ADP-Glo data showing effects of the indicated compounds on the activity of a purified N112C-CCNE1:CDK2 complex as measured by phosphorylation of the C-terminal peptide of RB1 (left) or the histone H1 protein (right). The N112C-CCNE1:CDK2 complex was pre-treated with compounds for 2 h (37 °C) before initiating phosphorylation reactions by addition of substrate. CI, confident intervals. Data represent average values ± s.e.m., n = 3. c , Gel-ABPP data showing concentration-dependent partial blockade of YZ-01-A engagement of N112-CCNE1 by I-125A and I-198, but not dinaciclib. Assays were performed in lysates from transfected HEK293T cells co-expressing NLuc-N112C-CCNE1 or NLuc-WT-CCNE1 and CDK2 that were treated with the indicated concentration ranges of compounds followed by YZ-01-A (10 μM, 90 min), anti-FLAG immunoprecipitation, and processing for gel-ABPP. d , Quantification of gel-ABPP data shown in c . Data represent average values ± s.e.m., n = 3. e , NanoBRET-ABPP data showing concentration-dependent partial blockade of YZ-01-A engagement of N112-CCNE1 by I-125A and I-198. Samples were treated with compounds as described in c prior to NanoBRET measurement. Data represent average values ± s.e.m., n = 3. f , Quantification of gel- and NanoBRET-ABPP data showing that dinaciclib does not substantially affect YZ-01-A engagement of N112C-CCNE1. Data represent average values ± s.e.m., n = 3.
Article Snippet: Briefly, different CCNE: CDK2 purified complexes at 4 ng μL −1 were mixed 1:1 with 2x compound stock (Both are made in kinase reaction buffer (40 mM Tris [pH = 7.6], 20 mM MgCl 2 , 0.1 mg mL −1 BSA and 50 μM DTT) and incubated at 37 °C for 1 h. Then 6 ng compound treated CCNE: CDK2 complexes (3 μL) were mixed with 2μL ATP/ CDK2 substrate mix to make final concentration of 150 μM ATP and 0.5 μg substrate per reaction (Substrate used is either histone H1(Sigma-Aldrich, 14-155) or
Techniques: Activity Assay, Purification, Concentration Assay, Transfection, Expressing, Immunoprecipitation
Journal: bioRxiv
Article Title: Expanding the ligandable proteome by paralog hopping with covalent probes
doi: 10.1101/2024.01.18.576274
Figure Lengend Snippet: a, b , ADP-Glo data showing effects of the indicated compounds on the activity of a purified WT-CCNE1:CDK2 ( a ) or WT-CCNE2:CDK2 ( b ) complexes as measured by phosphorylation of the C-terminal peptide of RB1 (left) or the histone H1 protein (right). The WT-CCNE:CDK2 complexes were pre-treated with compounds for 2 h (37 °C) before initiating phosphorylation reactions by addition of substrate. CI, confident intervals. Data represent average values ± s.e.m., n = 3. c , Gel-ABPP data showing concentration-dependent blockade of YZ-01-A engagement of N112C-CCNE1 following incubation with I-125A or I-198 for 30 min or 90 min. Experiment was performed as described in . Data are from a single experiment. d , Gel-ABPP data showing that residual YZ-01-A reactivity with N112C-CCNE1 in presence of 1 μM of I-125A or I-198 is stereoselective (greater than signals generated with YZ-01-B) and site-specific (greater than signals generated with WT-CCNE1). Experiments were performed as described in . Data represent average values ± s.e.m., n = 2. e , NanoBRET data showing concentration-dependent blockade of active site-directed tracer K-10 (0.2 μM) binding to N112C-CCNE1:CDK2-NLuc (left) or WT-CCNE1:CDK2-NLuc complexes by dinaciclib, but not I-125A. NanoBRET assays were performed in lysates of HEK293T cells recombinantly expressing the CCNE1:CDK2-NLuc complexes. Data represent average values ± s.e.m., n = 3.
Article Snippet: Briefly, different CCNE: CDK2 purified complexes at 4 ng μL −1 were mixed 1:1 with 2x compound stock (Both are made in kinase reaction buffer (40 mM Tris [pH = 7.6], 20 mM MgCl 2 , 0.1 mg mL −1 BSA and 50 μM DTT) and incubated at 37 °C for 1 h. Then 6 ng compound treated CCNE: CDK2 complexes (3 μL) were mixed with 2μL ATP/ CDK2 substrate mix to make final concentration of 150 μM ATP and 0.5 μg substrate per reaction (Substrate used is either histone H1(Sigma-Aldrich, 14-155) or
Techniques: Activity Assay, Purification, Concentration Assay, Incubation, Generated, Binding Assay, Expressing
Journal: Journal of Ginseng Research
Article Title: The role of ginseng and ginsenosides in ROS and cardiovascular disease
doi: 10.1016/j.jgr.2025.08.008
Figure Lengend Snippet: Modulation of signaling pathways by ginsenosides in exerting cardioprotective effect. Abbreviation ; Parkin signaling pathway (PINK), interleuking-1-beta (IL-1β), interleukin-6 (IL6), tumor necrosis factor (TNF), extracellular signal-regulated kinase (ERK1/2), c-Jun N-terminal kinase (JNK), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), sirutnin1 (SIRT1), nuclear factor kappa B (NF-κB), phosphoinositide3-kinase (PI3K), protein kinase B (Akt), mitogen-activated protein kinases (MAPK), yes-associated protein (YAP), ginsenoside Rg1 (Rg1), ginsenoside Rg3 (Rg3), ginsenoside Rb1 (Rb1), ginsenoside F 2 (F 2 ).
Article Snippet: Also,
Techniques: Protein-Protein interactions